Solventum Corporation SOLV NYSE

Solventum Corporation (SOLV) generated $95M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $63M, free cash flow was $32M.

Free cash flow margin was 1.6% of revenue. Cash conversion ratio was 1.51x, indicating earnings are backed by cash.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (71/100, Pass) — $32M (1.6% margin) supports a durable competitive advantage
• INCOME (70/100) — Cash conversion ratio was 1.51x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 73/100 with 6/7 criteria passed.